According to previous studies, the combination of an HDAC6 inhibitor and BTZ synergistically induced apoptosis in MM cells via inhibition of the proteasomal and aggresomal pathways of protein degradation and subsequent activation of apoptosis pathways (1, 25, 30). The gene discussed is HDAC6; the disease is Miyoshi myopathy.